Micromirs

Details for Australian Patent Application No. 2008306327 (hide)

Owner Santaris Pharma A/S

Inventors Lindow, Morten; Heidenblad, Marcus; Obad, Susanna; Kauppinen, Sakari; Elmen, Joacim

Agent FB Rice

Pub. Number AU-A-2008306327

PCT Pub. Number WO2009/043353

Priority 61/028,062 12.02.08 US; 60/979,217 11.10.07 US; 60/977,497 04.10.07 US; 08104780.5 17.07.08 EP

Filing date 3 October 2008

Wipo publication date 9 April 2009

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/043353 Priority application(s): WO2009/043353

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008306354-A call controlling method, base station subsystem and user terminal

2008306323-Inflatable chamber-pot